We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
+8.84%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$35.8B
AUM Growth
+$1.27B
Cap. Flow
-$817M
Cap. Flow %
-2.28%
Top 10 Hldgs %
13.63%
Holding
2,806
New
288
Increased
941
Reduced
1,236
Closed
310

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$563M
2
MCD icon
McDonald's
MCD
+$357M
3
TSLA icon
Tesla
TSLA
+$268M
4
AMD icon
Advanced Micro Devices
AMD
+$253M
5
PYPL icon
PayPal
PYPL
+$250M

Sector Composition

Rank Sector Weight
1 Technology 24.67%
2 Healthcare 17.85%
3 Industrials 11.58%
4 Financials 11.17%
5 Consumer Discretionary 10.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIVE
2426
HIVE Digital Technologies
HIVE
$746M
$21.3K ﹤0.01%
+14,760
New +$37.7K
STRR
2427
DELISTED
Star Equity Holdings
STRR
$20.9K ﹤0.01%
4,900
-480
-9% -$2.34K
XWEL icon
2428
XWELL
XWEL
$9.12M
$20.3K ﹤0.01%
2,795
-3,065
-52% -$34K
MTCR
2429
DELISTED
Metacrine, Inc. Common Stock
MTCR
$19.8K ﹤0.01%
44,200
-18,300
-29% -$7.57K
GRTX
2430
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$19.7K ﹤0.01%
13,200
-900
-6% -$1.46K
CDTX
2431
DELISTED
Cidara Therapeutics
CDTX
$19.5K ﹤0.01%
1,290
-120
-9% -$1.43K
WGS icon
2432
GeneDx Holdings
WGS
$1.89B
$18.4K ﹤0.01%
+2,112
New +$46.5K
CRDL
2433
Cardiol Therapeutics
CRDL
$137M
$18.3K ﹤0.01%
35,900
FBIO icon
2434
Fortress Biotech
FBIO
$111M
$18.1K ﹤0.01%
1,847
TOON icon
2435
Kartoon Studios
TOON
$34.4M
$18.1K ﹤0.01%
+3,890
New +$25.1K
LVO icon
2436
LiveOne
LVO
$64.1M
$17.7K ﹤0.01%
2,750
-1,310
-32% -$8.96K
DS
2437
DELISTED
Drive Shack Inc.
DS
$17.6K ﹤0.01%
105,200
-39,000
-27% -$17.8K
RAVE icon
2438
RAVE Restaurant Group
RAVE
$44.1M
$17.5K ﹤0.01%
11,100
-300
-3% -$479
QMCO icon
2439
Quantum Corp
QMCO
$437M
$16.7K ﹤0.01%
765
-2,585
-77% -$63.5K
CLWT icon
2440
Euro Tech Holdings
CLWT
$11.6M
$16.2K ﹤0.01%
11,350
-150
-1% -$214
GIGM icon
2441
GigaMedia
GIGM
$15M
$16K ﹤0.01%
13,200
+200
+2% +$246
RVLP
2442
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$15.8K ﹤0.01%
14,100
CYCN icon
2443
Cyclerion Therapeutics
CYCN
$15.5M
$15.6K ﹤0.01%
1,190
-640
-35% -$7.57K
SNCE
2444
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$15.4K ﹤0.01%
+1,855
New +$36.3K
EOSE icon
2445
Eos Energy Enterprises
EOSE
$1.21B
$15.4K ﹤0.01%
+10,400
New +$13.5K
SQFT icon
2446
Presidio Property Trust
SQFT
$3.01M
$14.6K ﹤0.01%
1,540
-620
-29% -$6.99K
CARM
2447
DELISTED
Carisma Therapeutics
CARM
$13.8K ﹤0.01%
+1,130
New +$11.9K
TMDI
2448
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$13.5K ﹤0.01%
20,500
-5,100
-20% -$2.69K
HYRE
2449
DELISTED
HyreCar Inc. Common Stock
HYRE
$13.5K ﹤0.01%
31,900
+500
+2% +$315
ZH
2450
Zhihu
ZH
$280M
$13.5K ﹤0.01%
1,733
-134
-7% -$938

Similar funds

Two Sigma Advisers's Q4 2022 Portfolio in Review

As of Q4 2022, Two Sigma Advisers held 2,806 positions worth $35.8B, up 3.7% from $34.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Two Sigma Advisers's Q4 2022 filing shows 288 new, 941 increased, 1,236 reduced and 310 closed positions. Its largest new stake was Advanced Micro Devices: 3,833,640 shares worth $248M. The largest sale was JPMorgan Chase, an estimated $485M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.

  • Two Sigma Advisers's largest Q4 2022 buy was Advanced Micro Devices: 3,833,640 shares worth $248M.
  • Two Sigma Advisers added most to Amazon in Q4 2022, an estimated $563M increase.
  • Two Sigma Advisers's biggest Q4 2022 reduction was JPMorgan Chase, cutting an estimated $485M.
  • Two Sigma Advisers fully exited NVIDIA in Q4 2022, selling an estimated $140M.
  • Two Sigma Advisers's ten largest holdings make up 14% of its $35.8B portfolio in Q4 2022.
  • Two Sigma Advisers opened 288 new positions and closed 310 in Q4 2022.
  • Two Sigma Advisers's portfolio value rose 3.7% quarter-over-quarter to $35.8B.

Based on Two Sigma Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.